We highly recommend enabling Javascript while using the BlackBoxRX site.


Suicidal Ideation and Behavior

  • Suicidal ideation and behavior, including completed suicides, have occurred in patients treated with SILIQ. 
  • Prior to prescribing, weigh potential risks and benefits in patients with a history of depression and/or suicidal ideation or behavior. Patients with new or worsening suicidal thoughts and behavior should be referred to a mental health professional, as appropriate. 
  • Advise patients and caregivers to seek medical attention for manifestations of suicidal ideation or behavior, new onset or worsening depression, anxiety, or other mood changes. 
  • SILIQ is available only through a restricted program called the SILIQ REMS Program. 

Approved Risk Evaluation and Mitigation Strategies (REMS)

SILIQ (Brodalumab) Injection

Patient Counseling Information

Medication Guides

Patient Medication Guide

Package Inserts


Updated January 2018